YU57994A - PROCEDURE FOR INACTIVING VIRUS IN THE PRESENCE OF POLYALKYLENGLICOL AND THE PHARMACEUTICAL PREPARATION OBTAINED BY THIS PROCEDURE - Google Patents

PROCEDURE FOR INACTIVING VIRUS IN THE PRESENCE OF POLYALKYLENGLICOL AND THE PHARMACEUTICAL PREPARATION OBTAINED BY THIS PROCEDURE

Info

Publication number
YU57994A
YU57994A YU57994A YU57994A YU57994A YU 57994 A YU57994 A YU 57994A YU 57994 A YU57994 A YU 57994A YU 57994 A YU57994 A YU 57994A YU 57994 A YU57994 A YU 57994A
Authority
YU
Yugoslavia
Prior art keywords
procedure
polyalkylenglicol
inactiving
virus
pharmaceutical preparation
Prior art date
Application number
YU57994A
Other languages
Serbo-Croatian (sh)
Inventor
J. Eibl
F. Dorner
N. Barrett
Original Assignee
Immuno Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag. filed Critical Immuno Ag.
Publication of YU57994A publication Critical patent/YU57994A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Pronalazak se odnosi na farmaceutski preparat koji sadrži protein plazme, koji je preparat bez infektivnih agensa kao i po mogućnosti bez proizvoda denaturisanja, i može se dobiti postupkom koji obuhvata sledece stupnjeve: a) dodavanje polietra rastvoru koji sadrži protein plazme, a u datom slučaju liofilizacija rastvora, b) inaktiviranje infektivnih agensa i prisustvu polietra fizičko-hemijskom ili hemijskom obradom, i c) odstranjivanje polietra.The invention relates to a pharmaceutical composition comprising plasma protein, which is a composition without infectious agents and preferably without denaturing products, and can be obtained by a process comprising the following steps: a) adding polyether to a solution containing plasma protein, and optionally lyophilizing the solution , b) inactivating infectious agents and the presence of polyether by physicochemical or chemical treatment, and c) removing the polyether.

YU57994A 1993-10-06 1994-10-06 PROCEDURE FOR INACTIVING VIRUS IN THE PRESENCE OF POLYALKYLENGLICOL AND THE PHARMACEUTICAL PREPARATION OBTAINED BY THIS PROCEDURE YU57994A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4334087 1993-10-06
DE4434538A DE4434538C2 (en) 1993-10-06 1994-09-27 Virus inactivation method in the presence of a polyether and a chaotropic agent

Publications (1)

Publication Number Publication Date
YU57994A true YU57994A (en) 1997-05-28

Family

ID=6499553

Family Applications (1)

Application Number Title Priority Date Filing Date
YU57994A YU57994A (en) 1993-10-06 1994-10-06 PROCEDURE FOR INACTIVING VIRUS IN THE PRESENCE OF POLYALKYLENGLICOL AND THE PHARMACEUTICAL PREPARATION OBTAINED BY THIS PROCEDURE

Country Status (2)

Country Link
DE (2) DE4434538C2 (en)
YU (1) YU57994A (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP940645A2 (en) * 1993-10-06 1996-12-31 Immuno Ag Process for virus deactivation in the presence of polyalkylene glycol and the pharmaceutical preparation thus obtained
DE4424935C1 (en) * 1994-07-14 1996-03-21 Immuno Ag Human virus-safe monomeric immunoglobulin A and process for its preparation
DE4435485C1 (en) * 1994-10-04 1996-03-21 Immuno Ag Process for obtaining high-purity von Willebrand factor
US6005077A (en) * 1995-11-10 1999-12-21 Immuno Aktiengesellschaft Use of von willebrand factor and pharmaceutical formulation
DE19600939C1 (en) 1996-01-12 1997-08-28 Immuno Ag Procedure for the separation of IgG and IgA
US6068838A (en) * 1996-04-29 2000-05-30 Baxter Aktiengesellschaft Purified multimerase
AT406120B (en) 1997-08-28 2000-02-25 Immuno Ag TISSUE ADHESIVE
AT405739B (en) 1997-09-19 1999-11-25 Immuno Ag METHOD FOR PURIFYING ANTITHROMBIN III

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727027A (en) * 1983-05-02 1988-02-23 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US4764369A (en) * 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
JPH0669961B2 (en) * 1984-09-25 1994-09-07 株式会社ミドリ十字 Immunoglobulin heat treatment method
JPH0662436B2 (en) * 1986-05-19 1994-08-17 株式会社ミドリ十字 Method for producing intravenous immunoglobulin preparation
DK0399321T3 (en) * 1989-05-24 1993-08-09 Miles Inc Gel filtration of heat treated factor VIII
JP3297433B2 (en) * 1989-06-15 2002-07-02 ローヌ−プーラン ローラー インターナショナル （ホウルディングス） インコーポレイテッド Method for inactivating viruses in pharmaceutical compositions contaminated with viruses
JP3145696B2 (en) * 1990-10-05 2001-03-12 日本ケミカルリサーチ株式会社 Method for producing secretory immunoglobulin A preparation

Also Published As

Publication number Publication date
DE4434538C2 (en) 2000-08-10
DE4434538A1 (en) 1995-04-13
DE59410031D1 (en) 2002-02-21

Similar Documents

Publication Publication Date Title
ES2087156T3 (en) METHODS FOR THE INACTIVATION OF VIRUSES IN PHARMACEUTICAL COMPOSITIONS CONTAMINATED BY VIRUSES.
DE3382042D1 (en) STERILIZED PLASMA LEVEL PRODUCTS AND PRODUCTION METHOD.
DE69535758D1 (en) LIPID ANALOGUE FOR THE TREATMENT OF VIRAL INFECTIONS
ATE327246T1 (en) HEPATITIS C TRIPEPTIDE INHIBITORS
EA199901031A1 (en) Derivatives of benzimidazole
SG52628A1 (en) Substituted cyclic carbonyls and derivatives thereof useful as retrobiral protease inhibitors
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
DE60105424D1 (en) METHODS FOR TREATING DELTA HEPATITIS VIRUS INFECTIONS WITH BETA-L-2 'DEOXY NUCLEOSIDES
FI961536A0 (en) Procedure for inactivating viruses in the presence of polyalkylene glycol and thus obtained pharmaceutical preparation
EA200400026A1 (en) HIV PROTEASE INHIBITORS, CONTAINING THEIR COMPOSITIONS, THEIR PHARMACEUTICAL APPLICATIONS AND SUBSTANCES FOR THEIR SYNTHESIS
Chandra et al. Effectiveness of alternative treatments for reducing potential viral contaminants from plasma-derived products
ATE165345T1 (en) SULFONIC ACID DERIVATIVES FOR THE TREATMENT OF VIRUS DISEASES
YU57994A (en) PROCEDURE FOR INACTIVING VIRUS IN THE PRESENCE OF POLYALKYLENGLICOL AND THE PHARMACEUTICAL PREPARATION OBTAINED BY THIS PROCEDURE
KR950010898A (en) Sterilization of Recombinant Human Serum Albumin Pharmaceutical Formulations
EA199800526A1 (en) DERIVATIVES OF BENZIMIDAZOLE AND THEIR APPLICATION FOR THE TREATMENT OF VIRAL INFECTIONS
WO2001097824A3 (en) Use of phyllanthus constituents for treating or preventing infections caused by flaviviridae
EE9400068A (en) Mixtures for the treatment of hepatitis B virus (HBV) infection and diseases caused by it and the process of their preparation
WO2002056824A3 (en) Pressure cycling inactivation of pathogens in biological materials used for therapeutics or vaccines
DE3750886D1 (en) Use of an immunoglobulin-containing preparation for the prophylaxis and therapy of AIDS in humans.
DK0653939T3 (en) Use of a Hymenoptera Poison for the Preparation of a Drug for the Treatment of DNA Virus Infections
ES2175449T3 (en) PROCEDURE FOR THE DEACTIVATION OF VIRUSES WRAPPED BY LIPIDS, WITH LIPOPEPTIDES, AND NEW ANTIVIRICAL LIPOPEPTIDES.
DE69231465T2 (en) METHOD AND COMPOSITION FOR TREATING HERPES-LIKE DISEASES
ATE277186T1 (en) COMPOSITION OF TRANSDOMINANT VARIANTS OF VIRUS PROTEINS FOR ANTIVIRAL EFFECT
AU630249B2 (en) Prevention of glycoprotein enveloped virus infectivity by quinolyloxazole-2-ones
ID23516A (en) DRUG TOOLS AND METHODS FOR TREATMENT OF INFECTIONS CAUSED BY VIRUSES AND MICROBIAL AND DANGEROUS SYNDRomes.